vimarsana.com
Home
Live Updates
Evolving NSCLC Landscape: Comparing Recent Updates in Neoadj
Evolving NSCLC Landscape: Comparing Recent Updates in Neoadj
Evolving NSCLC Landscape: Comparing Recent Updates in Neoadjuvant and Perioperative Immunotherapy
An expert comparison of recent data on neoadjuvant and perioperative immunotherapy in resectable early-stage NSCLC, including CheckMate 77T, CheckMate-816, and KEYNOTE-671.
Related Keywords
,
Women Health ,
Digital Health ,
Population Health ,
Chemotherapy ,
Complete Response ,
Adjuvant Therapy ,
Pathologic Complete Response ,
Checkmate 816 ,
Immunotherapy ,
Checkmate 77t ,
Keynote 671 ,
Neoadjuvant Phase ,
Neoadjuvant Immune Checkpoint Inhibitor ,